Skip to content
buyWeak

Jennifer L. Callahan bought $1,491 of CING

SVP and CFO at Cingulate Inc.. 55 shares at an average of $27.10, traded Mar 15, 2022, filed Mar 22, 2024.

Conviction score
30
Value
$1,491
55 shares
Holdings after
2,333
+2% from before
From 52-week low
+23%
low $278.40, close $343.20
From 52-week high
-68%
high $1,068.00, as of Mar 15, 2022

Score components

  • Role
    CFO
    +22
  • Trade size
    $1k at market
    0
  • Relative to holdings
    Holdings up 2.4%
    0
  • Price context
    68% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -24.2%, 3m -50.0%, 6m -62.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CINGOct 13, 2026 · close 4.72
Since filing Mar 22, 2024: -66.1%SPY +53.7% · excess -119.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-24-011034, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 15, 2022POpen-market purchase
Common Stock
+55$27.10$1,4912,333Mar 22, 2024
Mar 15, 2022POpen-market purchase
Warrant to Purchase Common Stockderivative
+1,500$0.30$45121,030Mar 22, 2024

Related signals

Other insiders at Cingulate Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
62Notable
CINGbuy 5
Cingulate Inc.
Thomas Jeffrey Hargroves
director
$490k
97,276 shares
first purchase
40Moderate
CINGbuy 5
Cingulate Inc.
Matthew Brams
EVP and Chief Medical Officer
$9,808
1,946 shares
+72%
47Moderate
CINGbuy 5
Cingulate Inc.
Jennifer L. Callahan
SVP and CFO
$25k
4,864 shares
+2494%
56Moderate
CINGbuy 5
Cingulate Inc.
Shane J. Schaffer
Chief Executive Officer
$34k
6,809 shares
+202%
43Moderate
CINGbuy 5
Cingulate Inc.
Peter J. Werth
director
$98k
19,455 shares
+20%
40Moderate
CINGsell
Cingulate Inc.
Laurie Myers
EVP and COO
$841
202 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jennifer L. Callahan bought $1,491 of CING | InsiderTell